Holen Sie sich die Stockscreener-App
0.683
1.88%
0.0126
Schlusskurs vom Vortag:
$0.6704
Offen:
$0.6778
24-Stunden-Volumen:
816.42K
Relative Volume:
0.61
Marktkapitalisierung:
$82.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-93.61M
KGV:
-0.3237
EPS:
-2.11
Netto-Cashflow:
$-71.16M
1W Leistung:
+5.08%
1M Leistung:
-10.64%
6M Leistung:
-22.85%
1J Leistung:
-44.92%
1-Tages-Spanne:
$0.6746
$0.6934
1-Wochen-Bereich:
$0.63
$0.6999
52-Wochen-Spanne:
$0.561
$1.39
Immunic Inc Stock (IMUX) Company Profile
Firmenname
Immunic Inc
Sektor
Branche
Telefon
(332) 255-9818
Adresse
1200 AVENUE OF THE AMERICAS, NEW YORK
Vergleichen Sie IMUX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.683 | 80.64M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Eingeleitet | Roth Capital | Buy |
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-25 | Eingeleitet | William Blair | Outperform |
| 2024-11-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-27 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-04-15 | Eingeleitet | Aegis Capital | Buy |
| 2021-03-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-07 | Fortgesetzt | ROTH Capital | Buy |
| 2020-07-20 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-06-05 | Eingeleitet | Wedbush | Outperform |
| 2020-05-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-25 | Eingeleitet | ROTH Capital | Buy |
| 2019-07-11 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Immunic Inc Aktie (IMUX) Neueste Nachrichten
How does Immunic Inc (IMUX) change from a tortoise to a hare? - Setenews
Immunic’s long-term treatment hope for multiple sclerosis – ICYMI - Proactive financial news
Operating income of Immunic, Inc. – HAM:10VA - TradingView
Will Immunic Inc. stock deliver better than expected guidanceRisk Management & Real-Time Buy Signal Alerts - Newser
How risky is Immunic Inc. stock nowJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Will Immunic Inc. (10VA) stock return to pre crash levels2025 Fundamental Recap & Consistent Profit Alerts - Newser
How supply chain issues affect Immunic Inc. stockMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Why Immunic Inc. (10VA) stock is a strong analyst pickPortfolio Gains Summary & Technical Pattern Alert System - Newser
Can Immunic Inc. (10VA) stock withstand sector downturnsTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Is Immunic Inc. stock near bottom after declineOil Prices & Daily Momentum Trading Reports - Newser
How Immunic Inc. stock performs in stagflation2025 Investor Takeaways & Target Return Focused Picks - Newser
Immunic marks International Day of Persons with Disabilities with hope for MS sufferers - Proactive financial news
What consensus target says about Immunic Inc. (10VA) stockWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Why Immunic Inc. stock is considered a top pickPortfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Will Immunic Inc. (10VA) stock outperform Dow JonesTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
Will Immunic Inc. (10VA) stock outperform global peers2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
Immunic (IMUX) Stock Analysis Report | Financials & Insights - Benzinga
B. Riley Has Bullish Estimate for Immunic FY2025 Earnings - MarketBeat
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December - Sahm
What is B. Riley’s Forecast for Immunic FY2025 Earnings? - Defense World
Will Immunic Inc. (10VA) stock benefit from mergersWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - BỘ NỘI VỤ
What is B. Riley’s Estimate for Immunic Q1 Earnings? - Defense World
B. Riley Forecasts Immunic's Q1 Earnings (NASDAQ:IMUX) - MarketBeat
Immunic (NASDAQ: IMUX) to present at 8th Evercore ISI Healthcare Conference on Dec. 4 - Stock Titan
Immunic announces attendance at upcoming Evercore ISI Healthcare Conference - Proactive financial news
EQS-News: Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in Decemberboerse.de - boerse.de
Immunic Inc (IMUX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Analysts Offer Predictions for Immunic FY2025 Earnings - MarketBeat
Immunic FY2025 EPS Boosted by Brookline Capital Management - MarketBeat
Immunic (NASDAQ:IMUX) Upgraded at Chardan Capital - Defense World
Immunic Inc. (IMUX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Equities Analysts Issue Forecasts for Immunic Q1 Earnings - MarketBeat
How Immunic Inc. stock performs in weak economyJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Is Immunic Inc. stock a buy before product launchesQuarterly Profit Summary & Detailed Earnings Play Strategies - newser.com
Why Immunic Inc. stock is trending among retail traders2025 Institutional Moves & Weekly Watchlist for Consistent Profits - newser.com
Forecasting Immunic Inc. price range with options dataWeekly Investment Report & Fast Momentum Entry Tips - newser.com
Chardan Capital Initiates Coverage of Immunic (IMUX) with Buy Recommendation - MSN
Using portfolio simulators with Immunic Inc. includedJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - newser.com
Immunic Inc (IMUX) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Tangible book value per share of Immunic, Inc. – HAM:10VA - TradingView
Finanzdaten der Immunic Inc-Aktie (IMUX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):